383 results on '"Rautio, Jarkko"'
Search Results
2. Specific transport of temozolomide does not override DNA repair-mediated chemoresistance
3. A technological comparison of freeze-dried poly-ɛ-caprolactone (PCL) and poly (lactic-co-glycolic acid) (PLGA) nanoparticles loaded with clozapine for nose-to-brain delivery
4. Altering distribution profile of palbociclib by its prodrugs
5. Prodrugs
6. Towards New Delivery Agents for Boron Neutron Capture Therapy: Synthesis and In Vitro Evaluation of a Set of Fluorinated Carbohydrate Derivatives.
7. Corrigendum to “A technological comparison of freeze-dried poly-ɛ-caprolactone (PCL) and poly (lactic-co-glycolic acid) (PLGA) nanoparticles loaded with clozapine for nose-to-brain delivery” [J. Drug Deliv. Sci. Technol. 93 (March 2024), 105419]
8. Formulating Resveratrol and Melatonin Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Ocular Administration Using Design of Experiments
9. Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates
10. Molecular characteristics supporting l-Type amino acid transporter 1 (LAT1)-mediated translocation
11. Tetrazine Glycoconjugate for Pretargeted Positron Emission Tomography Imaging of trans-Cyclooctene-Functionalized Molecular Spherical Nucleic Acids
12. Amino Acid-Based Boron Carriers in Boron Neutron Capture Therapy (BNCT)
13. Targeting Glial Cells by Organic Anion-Transporting Polypeptide 1C1 (OATP1C1)-Utilizing l-Thyroxine-Derived Prodrugs
14. Altering distribution profile of palbociclib by its prodrugs
15. Prodrugs – Recent approvals and a glimpse of the pipeline
16. Development of Lyophilised Eudragit® Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration
17. Sweet Battle of the Epimers─Continued Exploration of Monosaccharide-Derived Delivery Agents for Boron Neutron Capture Therapy
18. Supplementary Figure S4 from Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth
19. Data from Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth
20. Supplementary Figure Legends from Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth
21. High-accuracy mass spectrometry for identification of sulphur-containing bioactive constituents and flavonoids in extracts of Raphanus sativus var. caudatus Alef (Thai rat-tailed radish)
22. Free fatty acid receptor 1 (GPR40) agonists containing spirocyclic periphery inspired by LY2881835
23. In-vitro dynamic dissolution/bioconversion/permeation of fosamprenavir using a novel tool with an artificial biomimetic permeation barrier and microdialysis-sampling
24. Amino acid ester prodrugs conjugated to the α-carboxylic acid group do not display affinity for the L-type amino acid transporter 1 (LAT1)
25. Structural Features Affecting the Interactions and Transportability of LAT1-Targeted Phenylalanine Drug Conjugates
26. Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure
27. Synthesis and In Vitro Evaluation of a Set of 6-Deoxy-6-thio-carboranyl d-Glucoconjugates Shed Light on the Substrate Specificity of the GLUT1 Transporter
28. Development of Sesamol Carbamate-L-Phenylalanine Prodrug Targeting L-Type Amino Acid Transporter1 (LAT1) as a Potential Antiproliferative Agent against Melanoma
29. Development of Lyophilised Eudragit ® Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration.
30. Amino acids as promoieties in prodrug design and development
31. Convenient microwave-assisted synthesis of lipophilic sulfenamide prodrugs of metformin
32. Structure–activity relationship study of compounds binding to large amino acid transporter 1 (LAT1) based on pharmacophore modeling and in situ rat brain perfusion
33. Prodrugs in medicinal chemistry and enzyme prodrug therapies
34. Structural Features Affecting the Interactions and Transportability of LAT1-Targeted Phenylalanine Drug Conjugates.
35. In Vitro and In Vivo Evaluation of a Sulfenamide Prodrug of Basic Metformin
36. Impact of a Novel Anti-Inflammatory Ketoprofen-Lysine Prodrug on Cerebral Pathology and Cognition in a Comorbid APP21 Transgenic Rat with Diet-Induced Metabolic Syndrome
37. Design, Synthesis and Brain Uptake of LAT1-Targeted Amino Acid Prodrugs of Dopamine
38. Determination of metformin and its prodrugs in human and rat blood by hydrophilic interaction liquid chromatography
39. Prodrug Approaches for CNS Delivery
40. Species differences in the intra-brain distribution of an L-type amino acid transporter 1 (LAT1) -utilizing compound between mice and rats
41. How Readily Does Ketorolac Penetrate Cerebrospinal Fluid in Children?
42. Novel Cyclic Phosphate Prodrug Approach for Cytochrome P450-activated Drugs Containing an Alcohol Functionality
43. Breakthroughs in medicinal chemistry: new targets and mechanisms, new drugs, new hopes-7
44. Breakthroughs in medicinal chemistry: new targets and mechanisms, new drugs, new hopes–7, editorial
45. Design for Optimized Topical Delivery: Prodrugs and a Paradigm Change
46. Plasma and cerebrospinal fluid concentrations of indomethacin in children after intravenous administration
47. Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders
48. Exploring the Biochemical Foundations of a Successful GLUT1-Targeting Strategy to BNCT: Chemical Synthesis and In Vitro Evaluation of the Entire Positional Isomer Library of ortho-Carboranylmethyl-Bearing Glucoconjugates
49. Midazolam Exhibits Characteristics of a Highly Permeable P-Glycoprotein Substrate
50. LAT1-mediated prodrug uptake: a way to breach the blood–brain barrier?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.